THE ASSOCIATION BETWEEN EXPRESSION OF UCP2 AND SENSITIVITY TO PLATINUM-BASED CHEMOTHERAPY FOR OVARIAN SEROUS CARCINOMA

被引：0
|
作者：
Kawanishi, M. [1 ]
Fukuda, T. [1 ]
Inoue, Y. [1 ]
Shimomura, M. [1 ]
Matsubara, H. [1 ]
Wada, T. [1 ]
Tasaka, R. [1 ]
Yasui, T. [1 ]
Sumi, T. [1 ]
机构：
[1] Osaka City Univ, Grad Sch Med, Obstet & Gynecol, Osaka, Japan
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2017年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ESGO7-0211
引用
收藏
页码：1495 / 1495
页数：1
相关论文
共 50 条
  • [31] Intratumoral lymphocyte density in serous ovarian carcinoma is superior to ERCC1 expression for predicting response to platinum-based therapy
    Boesmueller, Hans
    Haitchi-Petnehazy, Sophie
    Webersinke, Gerald
    Marschon, Renate
    Roithmeier, Franz
    Stummvoll, Wolfgang
    Fehm, Tanja
    Klier-Richter, Margit
    Bonzheim, Irina
    Staebler, Annette
    Fend, Falko
    VIRCHOWS ARCHIV, 2011, 459 (02) : 183 - 191
  • [32] The association between germline BRCA2 variants and sensitivity to platinum-based chemotherapy among men with metastatic prostate cancer
    Pomerantz, Mark M.
    Spisak, Sandor
    Jia, Li
    Cronin, Angel M.
    Csabai, Istvan
    Ledet, Elisa
    Sartor, A. Oliver
    Rainville, Irene
    O'Connor, Edward P.
    Herbert, Zachary T.
    Szallasi, Zoltan
    Oh, William K.
    Kantoff, Philip W.
    Garber, Judy E.
    Schrag, Deborah
    Kibel, Adam S.
    Freedman, Matthew L.
    CANCER, 2017, 123 (18) : 3532 - 3539
  • [33] Platinum based chemotherapy for Ovarian Carcinoma
    Kusumanto, Ardhanu
    BALI MEDICAL JOURNAL, 2020, 9 (01) : 404 - 407
  • [34] SOX18 Expression Predicts Response to Platinum-based Chemotherapy in Ovarian Cancer
    Pula, Bartosz
    Kobierzycki, Christopher
    Solinski, Daniel
    Olbromski, Matuesz
    Nowak-Markwitz, Ewa
    Spaczynski, Marek
    Kedzia, Witold
    Zabel, Maciej
    Dziegiel, Piotr
    ANTICANCER RESEARCH, 2014, 34 (08) : 4029 - 4037
  • [35] Optimal Time Interval between Neoadjuvant Platinum-Based Chemotherapy and Interval Debulking Surgery in High-Grade Serous Ovarian Cancer
    Andrikopoulou, Angeliki
    Theofanakis, Charalampos
    Markellos, Christos
    Kaparelou, Maria
    Koutsoukos, Konstantinos
    Apostolidou, Kleoniki
    Thomakos, Nikolaos
    Haidopoulos, Dimitrios
    Rodolakis, Alexandros
    Dimopoulos, Meletios-Athanasios
    Zagouri, Flora
    Liontos, Michalis
    CANCERS, 2023, 15 (13)
  • [36] Real-world TRAE association between niraparib and platinum-based chemotherapy
    Wang, Linli
    Zhou, Jieli
    Wang, Haibin
    Han, Wenling
    Fang, Chunyun
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [37] Links between fatty acids and expression of UCP2 and UCP3 mRNAs
    Thompson, MP
    Kim, D
    FEBS LETTERS, 2004, 568 (1-3) : 4 - 9
  • [38] Nimotuzumab plus platinum-based chemotherapy versus platinum-based chemotherapy alone in patients with recurrent or metastatic nasopharyngeal carcinoma
    Zhu, Yunshu
    Yang, Sheng
    Zhou, Shengyu
    Yang, Jianliang
    Qin, Yan
    Gui, Lin
    Shi, Yuankai
    He, Xiaohui
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [39] Association between the ERCC1 polymorphism and platinum-based chemotherapy effectiveness in ovarian cancer: a meta-analysis
    Tang, Ning
    Lyu, Dan
    Zhang, Yan
    Liu, Haiping
    BMC WOMENS HEALTH, 2017, 17
  • [40] Association between the ERCC1 polymorphism and platinum-based chemotherapy effectiveness in ovarian cancer: a meta-analysis
    Ning Tang
    Dan Lyu
    Yan Zhang
    Haiping Liu
    BMC Women's Health, 17
12345